Assessing Clinical Features and Outcome of Breast Cancer in PALB2 Mutation Carriers: the Palbreast Study

RecruitingOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

October 2, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Breast Cancer
Trial Locations (1)

41125

RECRUITING

Aou Modena, Modena

All Listed Sponsors
lead

Azienda Ospedaliero-Universitaria di Modena

OTHER